De La Rue PLC
27 December 2007
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY AND CONNECTED PERSONS
1. Name of Company
DE LA RUE PLC
2 & 3. Details of Transactions
NAME TRANSACTION NOTIFIED IN
ACCORDANCE WITH DR 3.1.4R
(1)(A) PDMR (1)(B) DIRECTOR
STEPHEN KING YES
TRACEY GRAHAM YES
JANE VAN AMMEL YES
ANDREW VAUGHAN YES
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify
the connected person
N/A
5. Indicate whether the notification is in respect of a holding
of the person referred to in 3 or 4 above or in respect of a non-beneficial
interest.
N/A
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares.
N/A
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them.
N/A
8. State the nature of the transaction.
N/A
9. Number of shares, debentures or financial instruments relating to shares
acquired.
N/A
10. Percentage of issued class acquired (treasury shares of that
class should not be taken into account when calculating percentage).
N/A
11. Number of shares, debentures or financial instruments relating
to shares disposed.
N/A
12. Percentage of issued class disposed (treasury shares of that
class should not be taken into account when calculating percentage).
N/A
13. Price per share or value of transaction.
N/A
14. Date and place of transaction.
N/A
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage).
N/A
16. Date issuer informed of transaction.
N/A
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17. Date of grant.
27 DECEMBER 2007
18. Period during which or date on which it can be exercised.
AWARDS WILL VEST ON 1 MARCH 2011 AND OPTIONS CAN BE EXERCISED FOR UP TO SIX
MONTHS AFTER VESTING.
19. Total amount paid (if any) for grant of the option.
OPTION PRICE IS 745.74P, THE SCHEME IS A SAVINGS RELATED SHARE OPTION
SCHEME
20. Description of shares or debentures involved (class and number).
STEPHEN KING 1,287 ORDINARY SHARES OF 29 16/21P EACH
TRACEY GRAHAM 257 ORDINARY SHARES OF 29 16/21P EACH
JANE VAN AMMEL 772 ORDINARY SHARES OF 29 16/21P EACH
ANDREW VAUGHAN 1,287 ORDINARY SHARES OF 29 16/21P EACH
21. Exercise price (if fixed at time of grant) or indication that
price is to be fixed at the time of exercise.
OPTION PRICE IS 745.74P
22. Total number of shares or debentures over which options held
following notification.
STEPHEN KING 161,265
TRACEY GRAHAM 65,017
JANE VAN AMMEL 34,560
ANDREW VAUGHAN 11,432
23. Any additional information.
THIS IS A GRANT OF OPTIONS UNDER THE DE LA RUE (1999) SHARESAVE SCHEME
WHICH IS OPEN TO ALL EMPLOYEES.
24. Name of contact and telephone number for queries
STEPHEN KING, GROUP FINANCE DIRECTOR - 01256 605321
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.